Dr. Reddy’s Laboratories has announced the launch of Obeda®, its oral semaglutide tablet for the treatment of Type 2 diabetes in India. The once-daily tablet...
Lupin has inaugurated Atharv Ability, an advanced multidisciplinary neuro-rehabilitation center in Delhi, marking a significant step toward strengthening specialized neurological care in India. The facility...